TD Private Client Wealth’s Prestige Consumer Healthcare PBH Stock Holding History

TD Private Client Wealth’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$851	Buy	+18	New	+$925	﹤0.01%	1493

Other funds holding PBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TD Private Client Wealth's PBH Position: Q2 2026 in Review

TD Private Client Wealth opened a new position in Prestige Consumer Healthcare (PBH) in Q2 2026: 18 shares worth $851. The stake represents ﹤0.01% of the portfolio and ranks #1493 among its holdings.

318 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

TD Private Client Wealth held 18 shares of Prestige Consumer Healthcare worth $851 as of Q2 2026.
Prestige Consumer Healthcare was a new TD Private Client Wealth position in Q2 2026.
Prestige Consumer Healthcare made up ﹤0.01% of TD Private Client Wealth's portfolio in Q2 2026, its #1493 holding.
318 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.